Preview

Experimental and Clinical Gastroenterology

Advanced search

Practical advices how to use “Systemitizing classifi cation of multifocal lesions of the mucosa of the digestive tract by non-steroidal antiinfl ammatory and antitrombotic drugs («Moscow classifi cation»)” for endoscopist, gastroenterologist, internist, surgeon and intensive care specialist

https://doi.org/10.31146/1682-8658-ecg-198-2-184-188

Abstract

The authors present a unique model of the unified diagnostic decision-support system in the form of alphanumeric characters, which has been developed based on the digestive endoscopy data and is used to interpret the digestive tract lesions resulting from NSAIDs and ATDs treatment (Moscow Classification).

About the Authors

L. B. Lazebnik
State budgetary institution of high professional education “Moscow State University of Medicine and Dentistry named after A. I. Evdokimov” of the Ministry of Healthcare of the Russian Federation
Russian Federation


G. V. Belova
Multidisciplinary Medical Center of the Bank of Russia
Russian Federation


References

1. Skripka A., et al. “Factors Affecting Trough Plasma Dabigatran Concentrations in Patients with Atrial Fibrillation and Chronic Kidney Disease”. High Blood Pressure and Cardiovascular Prevention 27.2 (2020): 151-156.

2. Hunt R., et al. “International Consensus on Guiding Recommendations for Management of Patients with Nonsteroidal Antiinflamma- tory Drugs Induced Gastropathy-ICON-G”. Euroasian Journal of Hepato-Gastroenterology 8.2 (2018): 148-160.

3. Drapkina OM., et al. “Interim guidelines: “Diseases of the digestive organs in the context of a new coronavirus infection pandemic (COVID-19)””. Profilakticheskaya Meditsina 23.3 (2020): 2120-2152.

4. Lazebnik LB., et al. “Recommendations for the prevention and treatment of esophago-gastro-entero-colopathy induced by nonsteroi- dal antiinflammatory drugs “nsaid””. Experimental and Clinical Gastroenterology 3 (2018): 4-18.

5. Lazebnik LB., et al. “Medicamentary gastroenteropathys (recommendations for prevention and treatment of gastroenteropathys, induced by nonsteroid antiinflammatory medicaments)”. Therapy 2.20 (2018): 18-33.

6. Lazebnik LB and Belova GV. “Systemtizing classification of multifocal lesions of the mucosa of the digestive tract by non-steroidal anti-inflammatory and antitrombotic drugs (“moscow classification”)”. Experimental and Clinical Gastroenterology 3 (2018): 19-27.

7. Lazebnik LB and Belova GV. “Systematizing classification of multifocal lesions of gastrointestinal mucosa caused by non-steroidal anti-inflammatory and antithrombotic agents (Moscow Classification)”. Therapy 3.21 (2018): 40-52.

8. Lazebnik LB., et al. “VI national guidelines for the diagnosis and treatment of acid-related and Helicobacter pylori-associated diseases (VI Moscow agreement)”. Experimental and Clinical Gastroenterology 2 (2017): 3-21.

9. Maev IV., et al. “Statements for an algorithm for the management of primary unexamined patients with symptoms of dyspepsia in primary health care”. Profilakticheskaya Meditsina 22.1 (2019): 35-42.

10. Buryachkovskaya LI., et al. “Algorithms and risk scales for thrombosis and bleeding in cardiology and neurology”. Moscow (2018): 104.

11. Kolbin AS., et al. “Research of real clinical practice”. Moscow. OKI Publishing House: Buki Vedi (2020): 208.


Review

For citations:


Lazebnik L.B., Belova G.V. Practical advices how to use “Systemitizing classifi cation of multifocal lesions of the mucosa of the digestive tract by non-steroidal antiinfl ammatory and antitrombotic drugs («Moscow classifi cation»)” for endoscopist, gastroenterologist, internist, surgeon and intensive care specialist. Experimental and Clinical Gastroenterology. 2022;(2):184-188. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-198-2-184-188

Views: 303


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1682-8658 (Print)